{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-192018","form_type":"8-K","ticker":"CLB","cik":"0001958086","company_name":"Core Laboratories Inc. /DE/","filed_at":"2026-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.319788+00:00","generated_at":"2026-05-15T02:24:36.569763+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Core Lab Q1 revenue $121.8M; GAAP EPS -$0.02, ex-items $0.06","bullets":["Revenue $121.8M, down 12% sequentially and flat year-over-year.","GAAP operating income $1.9M; ex-items $6.6M, down 58% sequentially.","GAAP loss per share $0.02; EPS ex-items $0.06, down 72% sequentially and 58% YoY.","Free cash flow $0.5M; net debt up $3.9M; leverage ratio 1.20.","Q2 dividend $0.01/sh, record May 11, payable June 1; repurchased 51,781 shares for $0.9M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-192018","json":"https://secwatch.observer/filing/0001193125-26-192018.json","markdown":"https://secwatch.observer/filing/0001193125-26-192018.md","text":"https://secwatch.observer/filing/0001193125-26-192018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958086/000119312526192018/0001193125-26-192018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958086/000119312526192018/clb-20260429.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T02:24:36.569763+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"11bb91080c7130759f692bf9efa4240d57d87984","claim":"Core Laboratories Inc. /DE/ reported the first quarter of 2026 results: revenue $121.8 MILLION, EPS $0.02.","evidence_excerpt":"results for the first quarter of 2026. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE CORE LAB REPORTS FIRST QUARTER 2026 RESULTS: • REVENUE OF $121.8 MILLION, DOWN 12% SEQUENTIALLY AND FLAT YEAR-OVER-YEAR • OPERATING INCOME OF $1.9 MILLION; EX-ITEMS, $6.6 MILLION, DOWN 58% SEQUENTIALLY AND 44% YEAR-OVER-YEAR • GAAP LOSS PER SHARE OF","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1958086/000119312526192018/0001193125-26-192018-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter of 2026"},{"label":"Revenue","value":"$121.8 MILLION"},{"label":"EPS","value":"$0.02"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}